Leading manufacturer of medicinal cannabis products in Switzerland

MediCrops is a leading research and development company based in Switzerland and develops medicinal cannabis products of the highest quality for the European market with a focus on the German-speaking region.

Gemeinsam mit seinem erfahrenen Ingenieursteam baut MediCrops eine Indoor-Produktionsstätte auf, die höchste Standards erfüllt und jede Woche eine neue Charge auf der Grundlage standardisierter und automatisierter Prozesse zu produzieren

Company Profile

MediCrops Holding AG focuses on the marketing of medicinal cannabis preparations containing tetrahydrocannabinol (‘THC’). 

During the 2021 financial year, MediCrops founded a Swiss subsidiary that will specialise in the production and processing of medicinal cannabis preparations. 

Corporate Governance

The corporate management team at MediCrops Holding AG aims to ensure that transparency and sustainable value are created for all stakeholders. 

The focus of the Board of Directors is on the Corporate Governance Framework to ensure a consistent implementation of the best practice standards in accordance with the ‘Swiss Code of Best Practice for Corporate Governance

Neues Projekt - 2022-04-27T170350.232
Forschung Medizinal Cannabis

Market

Cannabis is cultivated and exported worldwide. In Europe, cannabis is mainly cultivated in Germany, the Netherlands and Italy, and cultivation often takes place in so-called indoor facilities. Due to special cultivation conditions, higher crop yields are achieved than in open field cultivation.

The use of cannabis for medicinal purposes dates back a long way, especially in India and Middle Eastern countries.